abstract |
FIELD: pharmacology. n SUBSTANCE: invention relates to the field of medicine and pharmacy, namely to the application of the compound of formula I: n (I), n or its deuterated compound, or a pharmacologically acceptable salt for the preparation of a drug for the treatment of cerebral microangiopathy in a patient, wherein cerebral microangiopathy is a cerebral microbleed, and R 1 is an H, alkyl, or terminal alkenyl containing 1 to 5 carbon atoms, or -CH(CH 3 )(CH 2 ) 3 CH(CH 3 ) 2 . n EFFECT: invention provides the use of compounds that significantly improve the excretion of extravascular hemoglobin and can thus be used for the treatment of cerebral microangiopathy. n 13 cl, 7 dwg, 3 ex |